title: A new approach to measuring estrogen exposure and metabolism in epidemiologic studies.
abstract: Endogenous estrogen plays an integral role in the etiology of breast and endometrial cancer, and conceivably ovarian cancer. However, the underlying mechanisms and the importance of patterns of estrogen metabolism and specific estrogen metabolites have not been adequately explored. Long-standing hypotheses, derived from laboratory experiments, have not been tested in epidemiologic research because of the lack of robust, rapid, accurate measurement techniques appropriate for large-scale studies. We have developed a stable isotope dilution liquid chromatography-tandem mass spectrometry (LC-MS(2)) method that can measure concurrently all 15 estrogens and estrogen metabolites (EM) in urine and serum with high sensitivity (level of detection=2.5-3.0fmol EM/mL serum), specificity, accuracy, and precision [laboratory coefficients of variation (CV's) < or =5% for nearly all EM]. The assay requires only extraction, a single chemical derivatization, and less than 0.5mL of serum or urine. By incorporating enzymatic hydrolysis, the assay measures total (glucuronidated+sulfated+unconjugated) EM. If the hydrolysis step is omitted, the assay measures unconjugated EM. Interindividual differences in urinary EM concentrations (pg/mL creatinine), which reflect total EM production, were consistently large, with a range of 10-100-fold for nearly all EM in premenopausal and postmenopausal women and men. Correlational analyses indicated that urinary estrone and estradiol, the most commonly measured EM, do not accurately represent levels of total urinary EM or of the other EM. In serum, all 15 EM were detected as conjugates, but only 5 were detected in unconjugated form. When we compared our assay methods with indirect radioimmunoassays for estrone, estradiol, and estriol and enzyme-linked immunosorbent assays for 2-hydroxyestrone and 16alpha-hydroxyestrone, ranking of individuals agreed well for premenopausal women [Spearman r (r(s))=0.8-0.9], but only moderately for postmenopausal women (r(s)=0.4-0.8). Our absolute readings were consistently lower, especially at the low concentrations characteristic of postmenopausal women, possibly because of improved specificity. We are currently applying our EM measurement techniques in several epidemiologic studies of premenopausal and postmenopausal breast cancer.
authors.affiliation: Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA. zieglerr@mail.nih.gov
authors.forename: R G
authors.initials: RG
authors.lastname: Ziegler
authors.forename: J M
authors.initials: JM
authors.lastname: Faupel-Badger
authors.forename: L Y
authors.initials: LY
authors.lastname: Sue
authors.forename: B J
authors.initials: BJ
authors.lastname: Fuhrman
authors.forename: R T
authors.initials: RT
authors.lastname: Falk
authors.forename: J
authors.initials: J
authors.lastname: Boyd-Morin
authors.forename: M K
authors.initials: MK
authors.lastname: Henderson
authors.forename: R N
authors.initials: RN
authors.lastname: Hoover
authors.forename: T D
authors.initials: TD
authors.lastname: Veenstra
authors.forename: L K
authors.initials: LK
authors.lastname: Keefer
authors.forename: X
authors.initials: X
authors.lastname: Xu
mesh_terms: D002853:Chromatography, Liquid; D016021:Epidemiologic Studies; D004967:Estrogens / Q000008:administration & dosage* / Q000378:metabolism; D005260:Female; D006801:Humans; D057230:Limit of Detection; D008297:Male; D015203:Reproducibility of Results; D053719:Tandem Mass Spectrometry
chemical_list: D004967:Estrogens
references.citation: Curr Drug Metab. 2002 Jun;3(3):321-49
references.pmid: 12083324
references.citation: Mol Cell Endocrinol. 2009 Mar 25;301(1-2):272-81
references.pmid: 19007847
references.citation: Steroids. 2007 Jul;72(8):666-71
references.pmid: 17588628
references.citation: Carcinogenesis. 1998 Jan;19(1):1-27
references.pmid: 9472688
references.citation: Adv Exp Med Biol. 2008;630:148-65
references.pmid: 18637490
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):221-6
references.pmid: 15668498
references.citation: J Natl Cancer Inst Monogr. 2000;(27):113-24
references.pmid: 10963623
references.citation: Br J Cancer. 1996 Jun;73(12):1615-9
references.pmid: 8664140
references.citation: Cancer Epidemiol Biomarkers Prev. 1999 Jun;8(6):567-77
references.pmid: 10385149
references.citation: Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3411-8
references.pmid: 19064556
references.citation: Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):292-300
references.pmid: 20056650
references.citation: Anal Chem. 2007 Oct 15;79(20):7813-21
references.pmid: 17848096
references.citation: Biochim Biophys Acta. 2006 Aug;1766(1):63-78
references.pmid: 16675129
references.citation: J Steroid Biochem. 1980 Jan;12:503-8
references.pmid: 7421233
references.citation: Adv Clin Chem. 2004;38:135-49
references.pmid: 15521191
references.citation: J Natl Cancer Inst. 1993 Nov 17;85(22):1819-27
references.pmid: 8230262
references.citation: Br J Cancer. 2003 May 6;88(9):1394-9
references.pmid: 12778067
references.citation: J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):221-36
references.pmid: 15860265
references.citation: Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):81-7
references.pmid: 10667467
references.citation: Endocr Relat Cancer. 2008 Jun;15(2):485-97
references.pmid: 18509001
references.citation: J Steroid Biochem Mol Biol. 2004 Dec;92(5):399-411
references.pmid: 15698545
references.citation: J Natl Cancer Inst. 2002 Apr 17;94(8):606-16
references.pmid: 11959894
references.citation: Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1578-81
references.pmid: 16985015
references.citation: Anal Chem. 2005 Oct 15;77(20):6646-54
references.pmid: 16223252
references.citation: J Endocrinol. 1996 Sep;150 Suppl:S259-65
references.pmid: 8943806
references.citation: Endocrinology. 2003 Aug;144(8):3382-98
references.pmid: 12865317
references.citation: N Engl J Med. 2006 Jan 19;354(3):270-82
references.pmid: 16421368
references.citation: J Natl Cancer Inst. 2005 May 18;97(10):755-65
references.pmid: 15900045
references.citation: J Natl Cancer Inst Monogr. 2000;(27):95-112
references.pmid: 10963622
references.citation: Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2860-8
references.pmid: 19843676
references.citation: J Clin Endocrinol Metab. 2006 Oct;91(10):3791-7
references.pmid: 16882749
references.citation: Int J Biol Markers. 2010 Oct-Dec;25(4):185-94
references.pmid: 21161939
references.citation: Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1713-9
references.pmid: 17855686